No disrespect but you and many others appear to be confusing sclc with nsclc two vastly different beasts . Keytruda is a highly effective treatment for nsclc and is a market leader . Imugene is a highly effective treatment for nothing at the moment . Also please be aware that clinical cancer trials are of at least 8 years duration and no meaningful data is available for at least 2/3 years and that is only for stage 4 cancer . Oncologists cannot administer any form of experimental drug until a full course of the current preferred treatment has been completed .
Friday thoughts IMU, page-214
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.001(2.44%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.2¢ | 4.1¢ | $253.6K | 6.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 1281279 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 3686685 | 15 |
View Market Depth
| Last trade - 10.38am 18/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |